139 related articles for article (PubMed ID: 25418975)
1. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
Wang KH; Lin CJ; Liu CJ; Liu DW; Huang RL; Ding DC; Weng CF; Chu TY
Cancer Med; 2015 Jan; 4(1):43-55. PubMed ID: 25418975
[TBL] [Abstract][Full Text] [Related]
2. Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia.
Murakami I; Fujii T; Dan K; Saito M; Ohno A; Iwata T; Aoki D
J Clin Virol; 2013 Sep; 58(1):149-54. PubMed ID: 23871162
[TBL] [Abstract][Full Text] [Related]
3. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
5. High-resolution melting analysis of HPV-16L1 gene methylation: A promising method for prognosing cervical cancer.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Li X
Clin Biochem; 2015 Sep; 48(13-14):855-9. PubMed ID: 25982893
[TBL] [Abstract][Full Text] [Related]
6. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.
Clarke MA; Wentzensen N; Mirabello L; Ghosh A; Wacholder S; Harari A; Lorincz A; Schiffman M; Burk RD
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2125-37. PubMed ID: 23035178
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia.
Ding DC; Chiang MH; Lai HC; Hsiung CA; Hsieh CY; Chu TY
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):215-20. PubMed ID: 19819061
[TBL] [Abstract][Full Text] [Related]
9. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
10. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
[TBL] [Abstract][Full Text] [Related]
11. Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
Wisman GB; Nijhuis ER; Hoque MO; Reesink-Peters N; Koning AJ; Volders HH; Buikema HJ; Boezen HM; Hollema H; Schuuring E; Sidransky D; van der Zee AG
Int J Cancer; 2006 Oct; 119(8):1908-14. PubMed ID: 16736496
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.
Gomih A; Smith JS; North KE; Hudgens MG; Brewster WR; Huang Z; Skaar D; Valea F; Bentley RC; Vidal AC; Maguire RL; Jirtle RL; Murphy SK; Hoyo C
Int J Cancer; 2018 Aug; 143(3):552-560. PubMed ID: 29490428
[TBL] [Abstract][Full Text] [Related]
13. Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
Fiano V; Trevisan M; Fasanelli F; Grasso C; Marabese F; da Graça Bicalho M; de Carvalho NS; Maestri CA; Merletti F; Sacerdote C; De Marco L; Gillio-Tos A
Gynecol Oncol; 2018 Nov; 151(2):319-326. PubMed ID: 30172480
[TBL] [Abstract][Full Text] [Related]
14. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
15. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation in cervical carcinogenesis.
Yang HJ
Chin J Cancer; 2013 Jan; 32(1):42-8. PubMed ID: 22943599
[TBL] [Abstract][Full Text] [Related]
17. Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings.
Wang KH; Liu HW; Lin SR; Ding DC; Chu TY
Cancer Sci; 2009 Nov; 100(11):2175-80. PubMed ID: 19709077
[TBL] [Abstract][Full Text] [Related]
18. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia.
Kalantari M; Calleja-Macias IE; Tewari D; Hagmar B; Lie K; Barrera-Saldana HA; Wiley DJ; Bernard HU
J Virol; 2004 Dec; 78(23):12762-72. PubMed ID: 15542628
[TBL] [Abstract][Full Text] [Related]
19. Methylation of
Meršaková S; Holubeková V; Grendár M; Višňovský J; Ňachajová M; Kalman M; Kúdela E; Žúbor P; Bielik T; Lasabová Z; Danko J
Oncol Lett; 2018 Dec; 16(6):7166-7174. PubMed ID: 30546453
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.
Wilting SM; Miok V; Jaspers A; Boon D; Sørgård H; Lando M; Snoek BC; van Wieringen WN; Meijer CJ; Lyng H; Snijders PJ; Steenbergen RD
Oncotarget; 2016 Jul; 7(28):43805-43819. PubMed ID: 27270309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
